Hugh Wright

Statistics

Publications

Citations

H-Index

Active since

1967

Affiliations

National Centre for Infectious Diseases(Current)

The University of Queensland

Royal Brisbane and Women's Hospital

National University of Singapore

Hugh Wright is an author at National Centre for Infectious Diseases specializing in antimicrobial therapy, infectious diseases, and gram-negative bloodstream infection.

Publications per year

1967–2025

Publications

Meropenem-induced liver injury and beta-lactam cross-reactivity

Timothy Tattersall, Hugh Wright, Andrew M. Redmond · BMJ Case Reports · 2018 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial

David L. Paterson, Helmi Sulaiman, Po‐Yu Liu et al. · The Lancet Infectious Diseases · 2025 · 14 citations

Pharmacy, Clinical Sciences, Infectious Diseases +13

Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trial

Hugh Wright, Patrick N. A. Harris, Mark D. Chatfield et al. · Trials · 2021 · 12 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Screening in the early diagnosis and prevention of cardiovascular disease.

G. Pincherle, Hugh Wright · PubMed · 1967 · 10 citations

Medicine, Cardiology, Preventive Medicine +14

1–4 of 4